Examples of enormous price raises of old drugs


Written by: Andrew Pollack, journalist.

A more recent Pharma business strategies is to buy old neglected drugs and turning them into high-priced “specialty drugs.”

The high-prices of speciality drugs are often argued as necessary to keep the drugs on the marked, because of a small patient basis and high regulatory expenses.

The rare use of speciality drugs and following the low overall impact on health care budgets, along with the prospect of a huge profit margin for reinvestment in R&D (of more common diseases) is used as justification why the price raises are in fact a favour to society.


Daraprim (Turing): Raised to $750 a tablet from $13.50 a tablet.

Cycloserine (Rodelis): Raised to $10,800 for 30 tablets from $500 for 30 tablets.

Isuprel and Nitropress (Valeant): Raised by 525 percent and 212 percent respectively.

Doxycycline (Mylan): Raised to $1,849 a bottle from $20 a bottle.


Source: Andrew Pollack sep. 20, 2015, New York Times.

Link: http://www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html




Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s